The Effect of the PKC b Inhibitor Ruboxistaurin on Moderate Visual Loss: The PKC-DRS2 Trial Baseline Characteristics and Preliminary Results

Publication Type
Conference Paper
Year of Publication
2005
Authors
Aiello, LP; Vignati, L; Sheetz, MJ; Zhi, X; Girach, A; Davis, MD; Milton, RC; The PKC DRS2 Study Group
Secondary
American Academy of Ophthalmology
Date Published
14/10/2005
Location
Chicago, IL